Updated Jul 16, 2026
PARMAR KUSH has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.07M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-07-09 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale | 6.9K | $7.50 | $52K |
| 2025-07-09 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale | 20.1K | $7.50 | $151K |
| 2025-06-27 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale | 6.4K | $7.12 | $46K |
| 2025-06-27 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale | 18.6K | $7.12 | $132K |
| 2025-06-27 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale | 6.4K | $6.81 | $44K |
| 2025-06-27 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale | 18.6K | $6.81 | $127K |
| 2025-06-27 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale | 19.3K | $6.91 | $133K |
| 2025-06-27 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale | 55.7K | $6.91 | $385K |
PARMAR KUSH is a corporate insider — currently tracked as Director, 10% Owner of Entrada Therapeutics, Inc. (TRDA). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 8 open-market sales ($1.07M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live PARMAR KUSH profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.